Item 8.01 of this
Current Report on Form 8-K shall not be deemed to be filed for purposes of
the
Securities Exchange Act of 1934.
| Item 9.01 |
Financial
Statements and Exhibits.
|
|
(d)
|
Exhibits.
|
|
99.1
|
Letter
from Health Canada addressed to Generex Biotechnology Corporation
dated
April 17, 2008
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
GENEREX
BIOTECHNOLOGY CORPORATION
|
|
|
|
|
|
|
Dated:
April 30, 2008
|
By:
|
/s/ Rose
C. Perri
|
|
|
Chief
Operating Officer and
Chief
Financial Officer
(principal
financial officer)
|
|
|
|
|
|
EXHIBIT
INDEX
|
99.1
|
Letter
from Health Canada addressed to Generex Biotechnology Corporation
dated
April 17, 2008
|